Allogene Therapeutics, Inc. (ALLO) Q2 2026 Earnings Call Transcript

· seekingalpha.com

Allogene Therapeutics, Inc. (ALLO) Q2 2026 Earnings Call August 12, 2026 5:00 PM EDTCompany ParticipantsChristine Cassiano - Executive VP, Chief Corporate...

Presentation

Hello. Thank you for standing by and welcome to Allogene Therapeutics second quarter 2026 conference call. [Operator Instructions] Please be aware...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI